A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Moxifloxacin (Moxifloxacin)

Fluoroquinolone Antibacterial class · 20 generic manufacturers · 21 ANDAs filed at FDA.

First FDA approval2003-05-07
Generic availableYes · 20 mfrs
Shortage statusDiscontinued
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$41.8M in CY2024 Part D spend1.7M claims · 1.1M beneficiaries · 329 plans surveyed

Lowest NADAC
$1.73/unit
19 NDCs benchmarked, lowest of all strengths.
Average NADAC
$3.33
Across all dosage forms in distribution.
Highest NADAC
$31.77
Wide spread — brand-strength NDCs still in market.
Plans with PA
34 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Moxifloxacin used for?

Moxifloxacin is a Fluoroquinolone Antibacterial medication tracked in Medicare Part D.

Is there a generic for Moxifloxacin?

Yes. 21 ANDAs filed at FDA, 20 generic manufacturers currently shipping.

How much does my plan pay for Moxifloxacin?

Across 329 Part D plans, Moxifloxacin averages $3.33/unit (NADAC). Lowest available: $1.73/unit. Highest in distribution: $31.77/unit.

Is Moxifloxacin on the FDA shortage list?

Moxifloxacin has been discontinued by its manufacturer(s).

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Fluoroquinolone Antibacterial5 alternatives in D1
01
Ciprofloxacin
Brand: CILOXAN
$0.089Lowest NADAC
20Generic mfrs
$47.8MCY24 Part D spend
Compare →
02
Ciprofloxacin Otic Solution,
Fluoroquinolone Antibacterial
$6.93Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Levofloxacin
Fluoroquinolone Antibacterial
$0.109Lowest NADAC
21Generic mfrs
$23.6MCY24 Part D spend
Compare →
04
Levofloxacin In
Brand: Levofloxacin
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
05
Llevofloxacin
Brand: Levofloxacin
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (19 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.